rss
Br J Ophthalmol 2007;91:1354-1358 doi:10.1136/bjo.2007.116574
  • Extended report
    • Clinical science - Extended reports

Intravenous administration of clonidine reduces intraocular pressure and alters ocular blood flow

  1. Günther Weigert1,2,
  2. Hemma Resch1,
  3. Alexandra Luksch1,2,
  4. Herbert A Reitsamer3,
  5. Gabriele Fuchsjager-Mayrl1,2,
  6. Leopold Schmetterer1,4,
  7. Gerhard Garhofer1,2
  1. 1
    Department of Clinical Pharmacology, Medical University of Vienna, Austria
  2. 2
    Department of Ophthalmology, Medical University of Vienna, Austria
  3. 3
    Department of Ophthalmology and Optometry, Paracelsus University Salzburg, Austria
  4. 4
    Center of Biomedical Engineering and Physics, Medical University of Vienna, Austria
  1. Gerhard Garhöfer, Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria; gerhard.garhoefer{at}meduniwien.ac.at
  • Accepted 3 May 2007
  • Published Online First 30 May 2007

Abstract

Aim: To evaluate the effect of intravenously administered clonidine on ocular blood flow in healthy volunteers.

Methods: A randomised, double-masked, placebo-controlled, two-way crossover study was performed in 12 healthy young volunteers. Clonidine (0.2 μg/kg/min) or placebo was administered intravenously over 10 minutes. The effects of clonidine were studied at baseline and up to 150 minutes after infusion. Ocular haemodynamics were measured using laser Doppler flowmetry, laser Doppler velocimetry and a retinal vessel analyser.

Results: Clonidine significantly decreased mean arterial pressure (MAP) and intraocular pressure (IOP). Calculated ocular perfusion pressure decreased significantly by −8.7±8.7% after infusion of clonidine (p<0.01 vs placebo). Retinal arterial diameters increased by +4.4±2.7% (p = 0.012 vs placebo), whereas no significant change was observed in retinal veins. Red blood cell velocity decreased by –16±14% (p<0.01 vs placebo) after infusion of clonidine. Hence, calculated retinal blood flow decreased by –14±12% (p = 0.033 vs placebo). Choroidal blood flow increased by +18±19% (p<0.01 vs placebo) and optic nerve head blood flow increased by +16±23% (p = 0.046 vs placebo) 30 minutes after administration of clonidine but both returned to baseline thereafter.

Conclusion: The short-time increase in choroidal and optic nerve head blood flow indicates a transient vasodilatory effect of clonidine due to an unknown mechanism. The decrease in retinal blood flow indicates clonidine-induced vasoconstriction in the retinal microvasculature.

Footnotes

  • Funding: Supported by Grant 11214 from the Jubiläumsfonds der Österreichischen Nationalbank.

  • Competing interests: None declared.

  • Abbreviations:
    IOP

    intraocular pressure

    LDF

    laser Doppler flowmetry

    MAP

    mean arterial pressure

    OPP

    ocular perfusion pressure

    RBCs

    red blood cells

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.